We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$4.47B
AUM Growth
+$651M
Cap. Flow
+$520M
Cap. Flow %
11.65%
Top 10 Hldgs %
45.49%
Holding
114
New
23
Increased
28
Reduced
17
Closed
41

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$239M
2
POST icon
Post Holdings
POST
+$178M
3
AVGO icon
Broadcom
AVGO
+$133M
4
AMH icon
American Homes 4 Rent
AMH
+$122M
5
DISH
DISH Network Corp.
DISH
+$104M

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$115M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$84.3M
3
VYX icon
NCR Voyix
VYX
+$82.1M
4
TCOM icon
Trip.com Group
TCOM
+$78.8M
5
BURL icon
Burlington
BURL
+$72.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.08%
2 Consumer Staples 10.63%
3 Healthcare 8.57%
4 Technology 8.37%
5 Communication Services 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLP icon
76
CALL
Alerian MLP ETF
AMLP
$12.8B
– –
-406,400
Closed -$25.4M
BLMN icon
77
Bloomin' Brands
BLMN
$1.01B
– –
-1,228,382
Closed -$22.3M
BMRN icon
78
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-200,000
Closed -$21.1M
BURL icon
79
CALL
Burlington
BURL
$23.2B
– –
-250,000
Closed -$12.8M
BURL icon
80
Burlington
BURL
$23.2B
– –
-1,415,033
Closed -$72.2M
CHRS icon
81
Coherus Oncology
CHRS
$224M
– –
-784,176
Closed -$15.7M
FOLD
82
DELISTED
Amicus Therapeutics
FOLD
– –
-250,000
Closed -$3.5M
GNRC icon
83
CALL
Generac Holdings
GNRC
$12.8B
– –
-50,900
Closed -$1.53M
LRMR icon
84
Larimar Therapeutics
LRMR
$426M
– –
-38,230
Closed -$14.7M
NBIX icon
85
Neurocrine Biosciences
NBIX
$16.4B
– –
-452,090
Closed -$18M
NXPI icon
86
CALL
NXP Semiconductors
NXPI
$58.3B
– –
-805,200
Closed -$70.1M
NXPI icon
87
NXP Semiconductors
NXPI
$58.3B
– –
-584,048
Closed -$50.9M
PPG icon
88
CALL
PPG Industries
PPG
$26.5B
– –
-400,000
Closed -$35.1M
PPG icon
89
PPG Industries
PPG
$26.5B
– –
-250,000
Closed -$21.9M
SPR
90
PUT
DELISTED
Spirit AeroSystems
SPR
– –
-200,000
Closed -$9.67M
TCOM icon
91
CALL
Trip.com Group
TCOM
$28.9B
– –
-1,219,200
Closed -$38.5M
TEVA icon
92
Teva Pharmaceuticals
TEVA
$40.5B
– –
-1,493,439
Closed -$84.3M
VRTX icon
93
Vertex Pharmaceuticals
VRTX
$123B
– –
-200,000
Closed -$20.8M
VYX icon
94
NCR Voyix
VYX
$1.31B
– –
-5,882,556
Closed -$82.1M
WW
95
CALL
DELISTED
WW International
WW
– –
-1,004,800
Closed -$6.41M
XPO icon
96
CALL
XPO
XPO
$23.4B
– –
-578,279
Closed -$4.77M
XPO icon
97
XPO
XPO
$23.4B
– –
-578,279
Closed -$4.77M
CPAY icon
98
PUT
Corpay
CPAY
$25.8B
– –
-200,000
Closed -$27.5M
CMRX
99
DELISTED
Chimerix, Inc.
CMRX
– –
-335,422
Closed -$12.8M
CONN
100
CALL
DELISTED
Conn's Inc.
CONN
– –
-563,800
Closed -$13.6M
1 2 3
4
5

Similar funds

BC
Blueport Capital Fort Worth, Texas $5.8M AUM 4.95% 1-Year Est. Return
LBG
Lloyds Banking Group London, United Kingdom $7.15M AUM 0.75% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
ACM
Archer Capital Management New York $16.2M AUM 17.01% 1-Year Est. Return
MGFS
Miller Green Financial Services Spring, Texas $17.6M AUM
LA
Lexington Advisors New York $18.7M AUM 48.36% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
NMM
NGP MR Management Dallas, Texas $23.4M AUM 15.8% 1-Year Est. Return

Tourbillon Capital Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Tourbillon Capital Partners held 114 positions worth $4.47B, up 17% from $3.82B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Tourbillon Capital Partners deployed $520M of net new capital in Q4 2015, opening 23 new positions and adding to 28 existing holdings. Its largest new stake was Pfizer: 7,610,331 shares worth $233M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 24% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was Expedia Group, an estimated $115M trimmed.

  • Tourbillon Capital Partners's largest Q4 2015 buy was Pfizer: 7,610,331 shares worth $233M.
  • Tourbillon Capital Partners added most to Post Holdings in Q4 2015, an estimated $178M increase.
  • Tourbillon Capital Partners's biggest Q4 2015 reduction was Expedia Group, cutting an estimated $115M.
  • Tourbillon Capital Partners fully exited Teva Pharmaceuticals in Q4 2015, selling an estimated $84.3M.
  • Tourbillon Capital Partners's ten largest holdings make up 45% of its $4.47B portfolio in Q4 2015.
  • Tourbillon Capital Partners opened 23 new positions and closed 41 in Q4 2015.
  • Tourbillon Capital Partners's portfolio value rose 17% quarter-over-quarter to $4.47B.

Based on Tourbillon Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.